HAEM5:ALK-positive anaplastic large cell lymphoma: Difference between revisions
| [unchecked revision] | [unchecked revision] |
| Line 491: | Line 491: | ||
!Notes | !Notes | ||
|- | |- | ||
|LRP1B | |LRP1B<ref name=":4" /> | ||
|TSG | |TSG | ||
|19% | |19% | ||
| Line 512: | Line 512: | ||
| | | | ||
|- | |- | ||
|TP53 | |TP53<ref name=":4" /> | ||
|TSG | |TSG | ||
|11% | |11% | ||
| Line 593: | Line 593: | ||
!Gene; Genetic Alteration!!Pathway!!Pathophysiologic Outcome | !Gene; Genetic Alteration!!Pathway!!Pathophysiologic Outcome | ||
|- | |- | ||
| | |ALK; fusion protein derivatives | ||
| | |Ras-ERK: | ||
| | |Increased cell growth and proliferation | ||
|- | |- | ||
|EXAMPLE: CDKN2A; Inactivating mutations | |EXAMPLE: CDKN2A; Inactivating mutations | ||